维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

4篇 您的检索式：作者名="Almodóvar"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Phenotypic differences between familial versus sporadic ankylosing spondylitis:a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)显示文摘	Almodóvar R Font P Zarco-Montejo P		0，，05：	1
	2	The up-regulation of human Caspase-8 by Interferon in breast tulnor cells requires the induction and action of the transcription factor interferon regulatory factor-1显示文摘	Ruiz-Ruiz C Ruiz de Almodóvar C Rodríguez A	2004	The Journal of Biological Chemistry2004，279，19：	1
	3	Association of biomarkers of inflammation,cartilage and bone turnover with gender,disease activity,radiological damage and sacroiliitis by magnetic resonance imaging in patients with early spondyloarthritis显示文摘	Almodóvar R Ríos V Ocana S	2014	Clin Rheumatol2014，33，2：	1
	4	20mg多西环素片剂联合局部外用0.75%甲硝唑洗剂治疗酒渣鼻疗效的随机、双盲、安慰剂对照试验显示文摘Background: Subantimicrobial doses of doxycycline may improve outcomes in rosacea when combined with topical metronidazole and used as maintenance monotherapy. Objective: The purpose of this study was to evaluate the safety and efficacy of doxycycline hyclate 20 mg (subantimicrob- ial dose doxycycline) administered twice daily as an adjunct to metronidazole 0.75% topical lotion in the treatment of rosacea. Methods: Patients received subantimicrobial doses of doxycycline twice daily plus metronidazole (n=20) or placebo plus metronidazole (n=20) for 12 weeks. Subantimicrobial- dose doxycycline or placebo monotherapy continued for 4 weeks. The primary efficacy measure was change from baseline in total inflammatory lesions at weeks 2 and 16. Results: Total inflammatory lesions were reduced significantly (P =.048) by week 4 and by all subsequent visits in the subantimicrobial- dose doxycycline/metronidazole group compared with placebo/metronidazole. Changes from baseline increased over time and were maintained during subantimicrobial- dose doxycycline monotherapy. Conclusion: Adjunctive use of subantimicrobial dose doxycycline significantly reduced the clinical signs of rosacea compared with metronidazole alone and may be useful maintenance monotherapy.	Sanchez J. Somolinos A.L. Almodó var P.I. 冯义国	2006	世界核心医学期刊文摘(皮肤病学分册)2006，0，2：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费